Latest articles by Dr Mike Tubbs
-
The British software sector stars investors should buy now
Cover Story You might not think of the UK as a market full of promising tech stocks. But our small- and medium-sized companies are punching above their weight, says Dr Mike Tubbs.
Cover Story -
A memorable day for Biogen investors
Features Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
Features -
Protect your profits – buy firms with deep and wide moats
Tutorials Firms with strong brands, superior products or that exploit network effects are hard for competitors to keep up with. That means big profits for their investors. Mike Tubbs picks the best protected companies.
Tutorials -
RWS: translating tech into profits
Features RWS is a “picks-and-shovels” play for the technology sector, and boasts an excellent record, says Mike Tubbs.
Features -
The fledgling industries emerging from our universities
Tutorials Science and engineering departments are innovation incubators, and regularly launch companies involved in a wide range of exciting new fields. Dr Mike Tubbs explains how to invest in spin-outs.
Tutorials -
How ASML is profiting from Moore’s law
Features ASML’s cutting-edge technology will capitalise on the growing demand for computer chips, says Mike Tubbs.
Features -
Want to profit from a gold rush? Invest in the picks and shovels
Tutorials Investing in a booming industry can be a risky business – only a lucky few will strike gold and produce the hot products of the future. There’s a much safer way to bet on fast-growing sectors, says Dr Mike Tubbs.
Tutorials -
The pharmas making pills tailored to your genes
Cover Story Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the companies best-placed to profit.
Cover Story -
How to spot tomorrow’s big stocks today
Tutorials Technological advances have transformed our day-to-day lives – and made fortunes for sharp-eyed investors. But how do you spot future innovators? Dr Mike Tubbs investigates.
Tutorials -
How to invest in the next big medical breakthrough
Cover Story There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company to break through, says Dr Mike Tubbs.
Cover Story -
How to invest in the fight against cancer
Features A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.
Features
